Heart Failure and Adipose Mesenchymal Stem Cells

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Metabolic Disease

Background:

• Mesenchymal stem cells (MSCs) are investigated for heart failure (HF) therapy.
• Adipose-derived MSCs are a focus, but linked to obesity, an independent HF risk factor.
• MSCs express the renin-angiotensin system (RAS), crucial in HF pathophysiology.

Purpose of the Study:

• To review the intricate relationship between heart failure and adipose MSCs.
• To explore how this association can be leveraged for improved HF therapeutics.
• To examine the role of the local RAS in MSC adipogenesis and HF.

Main Methods:

• Literature review of existing studies on MSCs, HF, obesity, and RAS.
• Analysis of the connection between MSC adipogenesis, obesity, and HF development.
• Synthesis of evidence regarding the therapeutic potential and challenges of adipose MSCs in HF.

Main Results:

• Adipose MSCs contribute to adipogenesis, potentially exacerbating obesity-related HF.
• The renin-angiotensin system within MSCs links adipogenesis, obesity, and HF.
• Understanding this complex interplay is key to harnessing MSCs for HF treatment.

Conclusions:

• Adipose MSCs present a dual role in HF, offering therapeutic promise but also posing risks due to their link with obesity.
• Targeting the MSC-adipogenesis-RAS axis may offer novel strategies for managing HF.
• Further research is needed to optimize adipose MSC-based therapies for heart failure.